Edward Sturchio
General Counsel en IMMATICS N.V. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Edward Sturchio is currently the General Counsel at Immatics NV since 2020.
Prior to this, he worked as the Secretary, Senior Vice President & General Counsel at Abeona Therapeutics, Inc. from 2019 to 2020, and as the Secretary & Global General Counsel at Advanced Accelerator Applications SA from 2016 to 2018.
He completed his undergraduate degree at Villanova University and his graduate degree at Seton Hall University School of Law.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMATICS N.V.
0.10% | 31/01/2024 | 106 875 ( 0.10% ) | 1 M $ | 31/03/2024 |
Cargos activos de Edward Sturchio
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMATICS N.V. | General Counsel | 01/06/2020 |
Antiguos cargos conocidos de Edward Sturchio.
| Empresas | Cargo | Fin |
|---|---|---|
| ABEONA THERAPEUTICS INC. | General Counsel | 01/02/2020 |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | General Counsel | 01/08/2018 |
Formación de Edward Sturchio.
| Villanova University | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| IMMATICS N.V. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
- Bolsa de valores
- Insiders
- Edward Sturchio
